@misc{misc, title  = {{392 Safety of amlitelimab in a Phase 2a clinical trial of patients with moderate-to-severe atopic dermatitis}},

 url = {{}},

 year = {{2023}},

 month = {{6}},

 author = {{Weidinger S and Cork M and Reich A and Bieber T and Gilbert S and Quaratino S and Wilson R and Porter-Brown B}},

 note = {{Accessed on 2024/12/22}}}